Table of Contents 1 Acute Respiratory Distress Syndrome Therapeutics Market Overview 1.1 Acute Respiratory Distress Syndrome Therapeutics Product Overview 1.2 Acute Respiratory Distress Syndrome Therapeutics Market Segment by Type 1.2.1 Methylprednisolone 1.2.2 Hydrocortisone 1.2.3 Calf Pulmonary Surfactant for Injection 1.2.4 Others 1.3 Global Acute Respiratory Distress Syndrome Therapeutics Market Size by Type 1.3.1 Global Acute Respiratory Distress Syndrome Therapeutics Sales and Growth by Type 1.3.2 Global Acute Respiratory Distress Syndrome Therapeutics Sales and Market Share by Type (2014-2019) 1.3.3 Global Acute Respiratory Distress Syndrome Therapeutics Revenue and Market Share by Type (2014-2019) 1.3.4 Global Acute Respiratory Distress Syndrome Therapeutics Price by Type (2014-2019) 2 Global Acute Respiratory Distress Syndrome Therapeutics Market Competition by Company 2.1 Global Acute Respiratory Distress Syndrome Therapeutics Sales and Market Share by Company (2014-2019) 2.2 Global Acute Respiratory Distress Syndrome Therapeutics Revenue and Share by Company (2014-2019) 2.3 Global Acute Respiratory Distress Syndrome Therapeutics Price by Company (2014-2019) 2.4 Global Top Players Acute Respiratory Distress Syndrome Therapeutics Manufacturing Base Distribution, Sales Area, Product Types 2.5 Acute Respiratory Distress Syndrome Therapeutics Market Competitive Situation and Trends 2.5.1 Acute Respiratory Distress Syndrome Therapeutics Market Concentration Rate 2.5.2 Global Acute Respiratory Distress Syndrome Therapeutics Market Share of Top 5 and Top 10 Players 2.5.3 Mergers & Acquisitions, Expansion 3 Acute Respiratory Distress Syndrome Therapeutics Company Profiles and Sales Data 3.1 Therabron Therapeutics, Inc. 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification 3.1.3 Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.1.4 Main Business Overview 3.2 Serendex Pharmaceuticals A/S 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification 3.2.3 Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.2.4 Main Business Overview 3.3 Silence Therapeutics Plc 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification 3.3.3 Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.3.4 Main Business Overview 3.4 Histocell S.L. 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification 3.4.3 Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.4.4 Main Business Overview 3.5 Altor BioScience Corporation 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification 3.5.3 Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.5.4 Main Business Overview 3.6 Athersys, Inc. 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification 3.6.3 Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.6.4 Main Business Overview 3.7 Faron Pharmaceuticals Oy 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification 3.7.3 Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.7.4 Main Business Overview 3.8 FirstString Research, Inc. 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification 3.8.3 FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.8.4 Main Business Overview 3.9 GlaxoSmithKline Plc 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification 3.9.3 GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.9.4 Main Business Overview 3.10 Phylogica Limited 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification 3.10.3 Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.10.4 Main Business Overview 4 Acute Respiratory Distress Syndrome Therapeutics Market Status and Outlook by Regions 4.1 Global Market Status and Outlook by Regions 4.1.1 Global Acute Respiratory Distress Syndrome Therapeutics Market Size and CAGR by Regions 4.1.2 North America 4.1.3 Asia-Pacific 4.1.4 Europe 4.1.5 South America 4.1.6 Middle East and Africa 4.2 Global Acute Respiratory Distress Syndrome Therapeutics Sales and Revenue by Regions 4.2.1 Global Acute Respiratory Distress Syndrome Therapeutics Sales and Market Share by Regions (2014-2019) 4.2.2 Global Acute Respiratory Distress Syndrome Therapeutics Revenue and Market Share by Regions (2014-2019) 4.2.3 Global Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019) 4.3 North America Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin 4.3.1 United States 4.3.2 Canada 4.3.3 Mexico 4.4 Europe Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin 4.4.1 Germany 4.4.2 UK 4.4.3 France 4.4.4 Italy 4.4.5 Russia 4.4.6 Turkey 4.5 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin 4.5.1 China 4.5.2 Japan 4.5.3 Korea 4.5.4 Southeast Asia 4.5.4.1 Indonesia 4.5.4.2 Thailand 4.5.4.3 Malaysia 4.5.4.4 Philippines 4.5.4.5 Vietnam 4.5.5 India 4.5.6 Australia 4.6 South America Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin 4.6.1 Brazil 4.7 Middle East and Africa Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue, Price and Gross Margin 4.7.1 Egypt 4.7.2 GCC Countries 5 Acute Respiratory Distress Syndrome Therapeutics Application/End Users 5.1 Acute Respiratory Distress Syndrome Therapeutics Segment by Application 5.1.1 In-Patient 5.1.2 Out-Patient 5.2 Global Acute Respiratory Distress Syndrome Therapeutics Product Segment by Application 5.2.1 Global Acute Respiratory Distress Syndrome Therapeutics Sales by Application 5.2.2 Global Acute Respiratory Distress Syndrome Therapeutics Sales and Market Share by Application (2014-2019) 6 Global Acute Respiratory Distress Syndrome Therapeutics Market Forecast 6.1 Global Acute Respiratory Distress Syndrome Therapeutics Sales, Revenue Forecast (2019-2025) 6.1.1 Global Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate Forecast (2019-2025) 6.1.1 Global Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate Forecast (2019-2025) 6.2 Global Acute Respiratory Distress Syndrome Therapeutics Forecast by Regions 6.2.1 North America Acute Respiratory Distress Syndrome Therapeutics Sales and Revenue Forecast (2019-2025) 6.2.2 Europe Acute Respiratory Distress Syndrome Therapeutics Sales and Revenue Forecast (2019-2025) 6.2.3 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Sales and Revenue Forecast (2019-2025) 6.2.3.1 China 6.2.3.2 Japan 6.2.3.3 Korea 6.2.3.4 Southeast Asia 6.2.3.5 India 6.2.3.6 Australia 6.2.4 South America Acute Respiratory Distress Syndrome Therapeutics Sales and Revenue Forecast (2019-2025) 6.2.5 Middle East and Africa Acute Respiratory Distress Syndrome Therapeutics Sales and Revenue Forecast (2019-2025) 6.2.5.1 Egypt 6.2.5.2 GCC Countries 6.3 Acute Respiratory Distress Syndrome Therapeutics Forecast by Type 6.3.1 Global Acute Respiratory Distress Syndrome Therapeutics Sales and Revenue Forecast by Type (2019-2025) 6.3.2 Methylprednisolone Gowth Forecast 6.3.3 Hydrocortisone Gowth Forecast 6.4 Acute Respiratory Distress Syndrome Therapeutics Forecast by Application 6.4.1 Global Acute Respiratory Distress Syndrome Therapeutics Sales Forecast by Application (2019-2025) 6.4.2 Global Acute Respiratory Distress Syndrome Therapeutics Forecast in In-Patient 6.4.3 Global Acute Respiratory Distress Syndrome Therapeutics Forecast in Out-Patient 7 Acute Respiratory Distress Syndrome Therapeutics Upstream Raw Materials 7.1 Acute Respiratory Distress Syndrome Therapeutics Key Raw Materials 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price 7.1.3 Raw Materials Key Suppliers 7.2 Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Acute Respiratory Distress Syndrome Therapeutics Industrial Chain Analysis 8 Marketing Strategy Analysis, Distributors 8.1 Marketing Channel 8.1.1 Direct Marketing 8.1.2 Indirect Marketing 8.1.3 Marketing Channel Development Trend 8.2 Distributors 8.3 Downstream Customers 9 Research Findings and Conclusion Appendix Methodology/Research Approach Research Programs/Design Market Size Estimation Market Breakdown and Data Triangulation Data Source Secondary Sources Primary Sources Disclaimer

List of Tables and Figures Figure Acute Respiratory Distress Syndrome Therapeutics Product Picture Figure Global Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD) Status and Outlook (2014-2025) Figure Global Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) Status and Outlook (2014-2025) Figure Product Picture of Methylprednisolone Table Major Players of Methylprednisolone Figure Global Methylprednisolone Sales (K Pcs) and Growth Rate (%)(2014-2018) Figure Product Picture of Hydrocortisone Table Major Players of Hydrocortisone Figure Global Hydrocortisone Sales (K Pcs) and Growth Rate (%)(2014-2019) Figure Product Picture of Calf Pulmonary Surfactant for Injection Table Major Players of Calf Pulmonary Surfactant for Injection Figure Global Calf Pulmonary Surfactant for Injection Sales (K Pcs) and Growth Rate (%)(2014-2019) Figure Product Picture of Others Table Major Players of Others Figure Global Others Sales (K Pcs) and Growth Rate (%)(2014-2019) Table Global Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) and Growth Rate (%) Comparison by Type Table Global Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) by Type (2014-2019) Table Global Acute Respiratory Distress Syndrome Therapeutics Sales Share (%) by Type (2014-2019) Figure Global Acute Respiratory Distress Syndrome Therapeutics Sales Market Share (%) by Type (2014-2019) Figure Global Acute Respiratory Distress Syndrome Therapeutics Sales Market Share (%) by Type in 2018 Table Global Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD) by Type (2014-2019) Table Global Acute Respiratory Distress Syndrome Therapeutics Revenue Share (%) by Type (2014-2019) Figure Global Acute Respiratory Distress Syndrome Therapeutics Revenue Share (%) by Type (2014-2019) Figure 2018 Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (%) by Type Table Global Acute Respiratory Distress Syndrome Therapeutics Price (USD/Pcs) by Type (2014-2019) Table Global Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) by Company (2014-2019) Table Global Acute Respiratory Distress Syndrome Therapeutics Sales Share (%) by Company (2014-2019) Figure Global Acute Respiratory Distress Syndrome Therapeutics Sales Share (%) by Company in 2018 Table Global Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD) by Company (2014-2019) Table Global Acute Respiratory Distress Syndrome Therapeutics Revenue Share (%) by Company (2014-2019) Figure Global Acute Respiratory Distress Syndrome Therapeutics Revenue Share (%) by Company in 2018 Table Global Market Acute Respiratory Distress Syndrome Therapeutics Average Price (USD/Pcs) by Company (2014-2019) Table Global Acute Respiratory Distress Syndrome Therapeutics Top Players Manufacturing Base Distribution and Sales Area Table Global Acute Respiratory Distress Syndrome Therapeutics Top Players Product Category Figure Global Acute Respiratory Distress Syndrome Therapeutics Market Share (%) of Top 5 Players Figure Global Acute Respiratory Distress Syndrome Therapeutics Market Share (%) of Top 10 Players Table Therabron Therapeutics, Inc. Basic Information List Table Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification Table Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales Growth Rate (2014-2019) Figure Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales Global Market Share (%)(2014-2019) Table Serendex Pharmaceuticals A/S Basic Information List Figure Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification Table Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Sales Growth Rate (2014-2019) Figure Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Sales Global Market Share (%)(2014-2019) Table Silence Therapeutics Plc Basic Information List Figure Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification Table Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Sales Growth Rate (2014-2019) Figure Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Sales Global Market Share (%)(2014-2019) Table Histocell S.L. Basic Information List Figure Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification Table Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Sales Growth Rate (2014-2019) Figure Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Sales Global Market Share (%)(2014-2019) Table Altor BioScience Corporation Basic Information List Figure Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification Table Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Sales Growth Rate (2014-2019) Figure Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Sales Global Market Share (%)(2014-2019) Table Athersys, Inc. Basic Information List Figure Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification Table Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales Growth Rate (2014-2019) Figure Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales Global Market Share (%)(2014-2019) Table Faron Pharmaceuticals Oy Basic Information List Figure Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification Table Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Sales Growth Rate (2014-2019) Figure Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Sales Global Market Share (%)(2014-2019) Table FirstString Research, Inc. Basic Information List Figure FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification Table FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales Growth Rate (2014-2019) Figure FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Sales Global Market Share (%)(2014-2019) Table GlaxoSmithKline Plc Basic Information List Figure GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification Table GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Sales Growth Rate (2014-2019) Figure GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Sales Global Market Share (%)(2014-2019) Table Phylogica Limited Basic Information List Figure Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Product Category, Application and Specification Table Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Sales Growth Rate (2014-2019) Figure Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Sales Global Market Share (%)(2014-2019) Table Global Acute Respiratory Distress Syndrome Therapeutics Market Size Comparison by Regions (2014-2025) Figure North America Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Europe Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure South America Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Middle East and Africa Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD) and Growth Rate (%)(2014-2025) Table Global Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) by Regions (2014-2019) Table Global Acute Respiratory Distress Syndrome Therapeutics Sales Market Share (%) by Regions (2014-2019) Figure Global Acute Respiratory Distress Syndrome Therapeutics Sales Market Share (%) by Regions (2014-2019) Figure 2018 Global Acute Respiratory Distress Syndrome Therapeutics Sales Market Share (%) by Regions Table Global Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD) by Regions (2014-2019) Table Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (%) by Regions (2014-2019) Figure Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (%) by Regions (2014-2019) Figure 2018 Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (%) by Regions Table Global Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure North America Acute Respiratory Distress Syndrome Therapeutics Sales Growth Rate Table North America Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure United States Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure United States Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure Canada Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure Canada Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure Mexico Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure Mexico Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure Europe Acute Respiratory Distress Syndrome Therapeutics Sales Growth Rate Table Europe Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Germany Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure Germany Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD) (2014-2019) Figure UK Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure UK Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure France Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure France Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure Italy Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure Italy Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure Russia Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure Russia Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure Turkey Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure Turkey Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Sales Growth Rate Table Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure China Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure China Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure Japan Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure Japan Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure Korea Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure Korea Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure Indonesia Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure Indonesia Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure Thailand Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure Thailand Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure Malaysia Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure Malaysia Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure Philippines Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure Philippines Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure Vietnam Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure Vietnam Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure India Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure India Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure Australia Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure Australia Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure South America Acute Respiratory Distress Syndrome Therapeutics Sales Growth Rate Table South America Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Brazil Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure Brazil Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure Middle East and Africa Acute Respiratory Distress Syndrome Therapeutics Sales Growth Rate Table Middle East and Africa Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure North Africa Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure North Africa Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure GCC Countries Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs)(2014-2019) Figure GCC Countries Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD)(2014-2019) Figure In-Patient Examples Figure Out-Patient Examples Table Global Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) Comparison by Application (2014-2025) Table Global Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) by Application (2014-2019) Table Global Acute Respiratory Distress Syndrome Therapeutics Sales Share (%) by Application (2014-2019) Figure Global Acute Respiratory Distress Syndrome Therapeutics Sales Market Share (%) by Application (2014-2019) Figure Global Acute Respiratory Distress Syndrome Therapeutics Sales Market Share (%) by Application in 2018 Figure Global Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Global Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025) Table Global Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) Forecast by Regions (2019-2025) Figure Global Acute Respiratory Distress Syndrome Therapeutics Sales Market Share (%) Forecast by Regions (2019-2025) Figure North America Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure North America Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Europe Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Europe Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure China Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure China Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Japan Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Japan Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Korea Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Korea Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure India Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure India Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Australia Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Australia Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure South America Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure South America Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure North Africa Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure North Africa Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Table Global Acute Respiratory Distress Syndrome Therapeutics Sales (Million USD) Forecast by Type (2019-2025) Figure Global Acute Respiratory Distress Syndrome Therapeutics Sales Market Share (%) Forecast by Type (2019-2025) Table Global Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD) Forecast by Type (2019-2025) Figure Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (%) Forecast by Type (2019-2025) Figure Methylprednisolone Sales Growth Forecast Figure Hydrocortisone Sales Growth Forecast Table Global Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) Forecast by Application (2019-2025) Figure Global Acute Respiratory Distress Syndrome Therapeutics Sales Forecast by Application (2019-2025) Figure Global Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) Forecast in In-Patient Figure Global Acute Respiratory Distress Syndrome Therapeutics Sales (K Pcs) Forecast in Out-Patient Table Key Raw Materials Lists Figure Key Raw Materials Price Table Raw Materials Key Suppliers Lists Figure Acute Respiratory Distress Syndrome Therapeutics Manufacturing Cost Structure Figure Acute Respiratory Distress Syndrome Therapeutics Industrial Chain Analysis Table Distributors List Table Acute Respiratory Distress Syndrome Therapeutics Downstream Customers

Therabron Therapeutics, Inc. Serendex Pharmaceuticals A/S Silence Therapeutics Plc Histocell S.L. Altor BioScience Corporation Athersys, Inc. Faron Pharmaceuticals Oy FirstString Research, Inc. GlaxoSmithKline Plc Phylogica Limited